The Shareholders Foundation announced that an investigation on behalf of investors of Globus Medical Inc (NYSE:GMED) shares was launched over potential securities laws violations by Globus Medical and certain of its directors and officers.
Investors who purchased shares of Globus Medical Inc (NYSE:GMED) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Globus Medical Inc (NYSE:GMED) concerning whether a series of statements by Globus Medical Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Globus Medical Inc reported that its annual Total Revenue increased from $385.99 million in 2012 to $434.46 million in 2013 while its Net Income declined from $73.83 million to $68.61 million.
Shares of Globus Medical Inc (NYSE:GMED) increased from $18.14 per share in August 2014 to as high as $25.80 per share on April 1, 2015.
On April 22, 2015 Globus Medical Inc announced that on April 16, 2015, KPMG LLP (“KPMG”) orally notified Globus Medical Inc that upon the completion of KPMG’s review of Globus Medical Inc’s consolidated financial statements for the quarterly reporting period ended March 31, 2015 and the filing of the related Quarterly Report on Form 10-Q, KPMG declines to stand for reelection as the independent registered public accounting firm for Globus Medical Inc. Shares of Globus Medical Inc (NYSE:GMED) declined on April 23, 2015, to $23.70 per share.
On May 4, 2015, NYSE:GMED shares closed at $23.86 per share.
Those who purchased shares of Globus Medical Inc (NYSE:GMED) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com